gip/glp 1-agonist tirzepatide Main physiological actions of the dual GIP and GLP-1 agonist New Weight-Loss Drugs Are Poised

Turn vial and syringe upside down

Drug developers are racing to enter the highly competitive and booming obesity market dominated by injectable drugs such as Novo Nordisks Wegovy and Lillys Zepbound, prompting heavy investment in next-generation treatments that could deliver faster, deeper, or more durable weight loss

Certain medical conditions and histories can make this type of medication a poor fit, which is why a proper medical review is always required before starting

Journal of Clinical Psychopharmacology

Compounded semaglutide is prepared by a licensed pharmacy to fill an individual prescription

Strength training increases insulin-mediated glucose uptake, GLUT4 content, and insulin signaling in skeletal muscle in patients with type 2 diabetes